Cargando…

Teratoid Hepatoblastoma—Our Experience

SIMPLE SUMMARY: Hepatoblastomas (HB) are the most common pediatric liver tumor with a number of histologic patterns described. Teratoid HB is a rare subtype with only a few case reports documented in the current literature. The aim of this study is to analyze a large series of teratoid HB to better...

Descripción completa

Detalles Bibliográficos
Autores principales: Berklite, Lara, Ranganathan, Sarangarajan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776033/
https://www.ncbi.nlm.nih.gov/pubmed/36551621
http://dx.doi.org/10.3390/cancers14246135
_version_ 1784855778589409280
author Berklite, Lara
Ranganathan, Sarangarajan
author_facet Berklite, Lara
Ranganathan, Sarangarajan
author_sort Berklite, Lara
collection PubMed
description SIMPLE SUMMARY: Hepatoblastomas (HB) are the most common pediatric liver tumor with a number of histologic patterns described. Teratoid HB is a rare subtype with only a few case reports documented in the current literature. The aim of this study is to analyze a large series of teratoid HB to better characterize the clinicopathologic features in order to aid in recognition and diagnosis, improve understanding of the biology of these tumors, and provide insights into clinical behavior that may inform future clinical trials. ABSTRACT: Hepatoblastomas (HB) are the most common pediatric liver tumor with several subgroups described, of which teratoid HB is the rarest. The aim of this study is to characterize the histologic and phenotypic spectrum of teratoid HB in order to better understand the biology and behavior of these tumors. A retrospective analysis of all teratoid HB diagnosed at a major pediatric hospital as well as the consultation files of one of the authors (SR) was performed with the available clinical data and surgical pathology material reviewed. A detailed immunohistochemical workup was also performed. A total of 28 cases were included from patients ranging from 5 to 84 months of age and a M:F ratio of 1.07:1. Four patients had syndromic associations. In 14/28 cases, the tumors contained primitive glandular elements with histologic and immunophenotypic overlap with the yolk sac tumor which in two cases became predominant in metastatic sites. One case had extensive primitive neural epithelium mimicking a primitive neuroectodermal tumor (PNET). Other unique elements included melanin, mature neuroglial tissue, rhabdomyoblastic differentiation, and neuroendocrine carcinoma-like areas (n = 2). In conclusion, this study provides the largest series of teratoid HB to date with clinical and outcome data, highlights previously undescribed or under-recognized histologic patterns in these tumors, and describes the immunohistochemical profile of these tumors to aid in diagnosis.
format Online
Article
Text
id pubmed-9776033
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97760332022-12-23 Teratoid Hepatoblastoma—Our Experience Berklite, Lara Ranganathan, Sarangarajan Cancers (Basel) Article SIMPLE SUMMARY: Hepatoblastomas (HB) are the most common pediatric liver tumor with a number of histologic patterns described. Teratoid HB is a rare subtype with only a few case reports documented in the current literature. The aim of this study is to analyze a large series of teratoid HB to better characterize the clinicopathologic features in order to aid in recognition and diagnosis, improve understanding of the biology of these tumors, and provide insights into clinical behavior that may inform future clinical trials. ABSTRACT: Hepatoblastomas (HB) are the most common pediatric liver tumor with several subgroups described, of which teratoid HB is the rarest. The aim of this study is to characterize the histologic and phenotypic spectrum of teratoid HB in order to better understand the biology and behavior of these tumors. A retrospective analysis of all teratoid HB diagnosed at a major pediatric hospital as well as the consultation files of one of the authors (SR) was performed with the available clinical data and surgical pathology material reviewed. A detailed immunohistochemical workup was also performed. A total of 28 cases were included from patients ranging from 5 to 84 months of age and a M:F ratio of 1.07:1. Four patients had syndromic associations. In 14/28 cases, the tumors contained primitive glandular elements with histologic and immunophenotypic overlap with the yolk sac tumor which in two cases became predominant in metastatic sites. One case had extensive primitive neural epithelium mimicking a primitive neuroectodermal tumor (PNET). Other unique elements included melanin, mature neuroglial tissue, rhabdomyoblastic differentiation, and neuroendocrine carcinoma-like areas (n = 2). In conclusion, this study provides the largest series of teratoid HB to date with clinical and outcome data, highlights previously undescribed or under-recognized histologic patterns in these tumors, and describes the immunohistochemical profile of these tumors to aid in diagnosis. MDPI 2022-12-13 /pmc/articles/PMC9776033/ /pubmed/36551621 http://dx.doi.org/10.3390/cancers14246135 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Berklite, Lara
Ranganathan, Sarangarajan
Teratoid Hepatoblastoma—Our Experience
title Teratoid Hepatoblastoma—Our Experience
title_full Teratoid Hepatoblastoma—Our Experience
title_fullStr Teratoid Hepatoblastoma—Our Experience
title_full_unstemmed Teratoid Hepatoblastoma—Our Experience
title_short Teratoid Hepatoblastoma—Our Experience
title_sort teratoid hepatoblastoma—our experience
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776033/
https://www.ncbi.nlm.nih.gov/pubmed/36551621
http://dx.doi.org/10.3390/cancers14246135
work_keys_str_mv AT berklitelara teratoidhepatoblastomaourexperience
AT ranganathansarangarajan teratoidhepatoblastomaourexperience